Bettina N.
- Country
- Denmark
- Department
- Urological Research Center
Research Overview
- Evaluation of 64Cu-DOTA-AE105 PET Imaging for ISUP Grade Classification in Localized, Untreated Prostate Cancer Patients
- Open-Label Extension Study on Long-Term Safety of Enzalutamide in Prostate Cancer Patients from Previous Clinical Trials
- Efficacy and Safety Evaluation of Enzalutamide and Leuprorelin Acetate in High-Risk Nonmetastatic Prostate Cancer Post-Definitive Therapy
Data & Insights
Has run more than one trial at 26 of 101 partner sites.
Specializations
Prostate Cancer Treatment
This investigator specializes in advanced therapeutic approaches for nonmetastatic prostate cancer, with particular focus on hormonal therapy combinations and novel treatment strategies.
- High-risk prostate cancer management
- Hormonal therapy optimization
- Post-definitive therapy progression
Their research encompasses treatment options for patients with progressive disease following initial therapy.
Long-term Treatment Evaluation
The investigator conducts comprehensive studies on extended therapeutic outcomes in prostate cancer patients, focusing on sustained clinical benefits and safety monitoring.
- Long-term safety assessment
- Treatment continuation benefits
- Clinical outcome tracking
Their work emphasizes the importance of continuous therapeutic assessment in prostate cancer care.
Diagnostic Innovation
The investigator explores advanced diagnostic imaging techniques for localized prostate cancer, particularly focusing on novel PET imaging methodologies.
- uPAR PET imaging applications
- Cancer grade classification
- Diagnostic performance assessment
Their research aims to enhance the accuracy of prostate cancer diagnosis and staging.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.